20150324 FY results 2014 full release_ENG FINAL
Category: Press release
Transgene Announces New Pre-Clinical Data with TG4010 in Combination with Immune Checkpoint Inhibitors and TG3003 (humanized mAb anti-CD115) to be Presented at AACR
18032015_AACR 2015 curtain raiser_EN
Transgene Announces Financial Calendar for 2015
20150107 PR 2015 financial calendar_EN_ver 1
Transgene Announces Third Quarter 2014 Financial Results
266_en
Transgene Reports Financial Results for First Six Months of 2014 and Provides Update on TG4010
261_en
Transgene Reports First Quarter 2014 Financial Results
254_en
Transgene Reports Fiscal Year 2013 Results and Provides Business Update
253_en